If you need more lookups,
subscriptions start at $34 USD/month.
Andrew Friedman Location
New Jersey, United States
Andrew Friedman Work
Executive Vice President Regulatory and Development Strategy @ (April 2021 - Present)
SVP Regulatory @ (January 2020 - April 2021)
Sr. Vice President - Head of Regulatory Affairs @ (June 2016 - January 2020)
VP Regulatory Affairs - Acute Cardiovascular Care @ (June 2014 - June 2016)
Executive Director - Global Regulatory Strategy - Cardiovascular and Genetically Defined Diseases @ (March 2014 - June 2014)
Exec Dir. - Neuroscience and Cardiovascular, Global Regulatory Strategy @ (January 2011 - March 2014)
Global Head - CNS Drug Regulatory Affairs @ (June 2005 - February 2011)
Drug Regulatory Affairs @ (January 2002 - January 2005)
Regulatory Affairs @ (January 1999 - January 2002)
Medical Program Coordinator @ (January 1997 - January 1999)
Andrew Friedman Education
Shenandoah University
Doctor of Pharmacy (Pharmacy)
2001-2003
Long Island University
Bachelors (Pharmacy)
1993-1997
City University Of New York - Brooklyn College
Bachelors (Communications)
1988-1992
Andrew Friedman Skills
Biomarkers
Biopharmaceuticals
Biotechnology
CRO
CTMS
Clinical Development
Clinical Trials
Drug Development
Drug Discovery
GCP
IND
Life Sciences
Lifesciences
Medicine
Neuroscience
Oncology
Pharmaceutical Industry
Regulatory Affairs
Regulatory Submissions
Strategy
Therapeutic Areas
Translational Medicine
Andrew Friedman Summary
Andrew Friedman, based in New Jersey, United States, is currently a Executive Vice President Regulatory and Development Strategy at Validae Health. Andrew Friedman brings experience from previous roles at Novartis, The Medicines Company and Bristol-Myers Squibb. Andrew Friedman holds a 2001 - 2003 Doctor of Pharmacy in Pharmacy @ Shenandoah University. With a robust skill set that includes Biomarkers, Biopharmaceuticals, Biotechnology, CRO, CTMS and more. Andrew Friedman has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andrew Friedman?
Find contact details for 700 million professionals.